KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Non-Current Deffered Revenue (2019 - 2021)

Hims & Hers Health's Non-Current Deffered Revenue history spans 3 years, with the latest figure at $384000.0 for Q1 2021.

  • For Q1 2021, Non-Current Deffered Revenue fell 94.55% year-over-year to $384000.0; the TTM value through Mar 2021 reached $384000.0, down 94.55%, while the annual FY2020 figure was $381000.0, 94.59% down from the prior year.
  • Non-Current Deffered Revenue for Q1 2021 was $384000.0 at Hims & Hers Health, up from $381000.0 in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $7.0 million in Q3 2019 and bottomed at $381000.0 in Q4 2020.
  • The 3-year median for Non-Current Deffered Revenue is $7.0 million (2019), against an average of $5.1 million.
  • The largest YoY upside for Non-Current Deffered Revenue was 0.0% in 2020 against a maximum downside of 94.59% in 2020.
  • A 3-year view of Non-Current Deffered Revenue shows it stood at $7.0 million in 2019, then crashed by 94.59% to $381000.0 in 2020, then increased by 0.79% to $384000.0 in 2021.
  • Per Business Quant, the three most recent readings for HIMS's Non-Current Deffered Revenue are $384000.0 (Q1 2021), $381000.0 (Q4 2020), and $7.0 million (Q3 2020).